Gene · 3399
Papers2,841
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 2,841
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prediction of the Immune Phenotypes of Bladder Cancer Patients for Precision Oncology. | IEEE Open J Eng Med Biol | 2022 | 35519421 | PubTator, text mining | PubMed |
| Dissecting Human Gonadal Cell Lineage Specification and Sex Determination Using A Single-cell RNA-seq Approach. | Genomics Proteomics Bioinformatics | 2022 | 35513251 | PubTator, text mining | PubMed |
| A systematic comparison of FOSL1, FOSL2 and BATF-mediated transcriptional regulation during early human Th17 differentiation. | Nucleic Acids Res | 2022 | 35511484 | PubTator, text mining | PubMed |
| IRF4 drives clonal evolution and lineage choice in a zebrafish model of T-cell lymphoma. | Nat Commun | 2022 | 35504924 | PubTator, text mining | PubMed |
| "If it is not made easy for me, I will just not bother". A qualitative exploration of the barriers and facilitators to recycling plastics. | PLoS One | 2022 | 35503782 | PubTator, text mining | PubMed |
| Epstein-Barr virus and malaria upregulate AID and APOBEC3 enzymes, but only AID seems to play a major mutagenic role in Burkitt lymphoma. | Eur J Immunol | 2022 | 35503749 | PubTator, text mining | PubMed |
| OVOL1 inhibits breast cancer cell invasion by enhancing the degradation of TGF-β type I receptor. | Signal Transduct Target Ther | 2022 | 35484112 | PubTator, text mining | PubMed |
| Hypoxia-reprogrammed regulatory group 2 innate lymphoid cells promote immunosuppression in pancreatic cancer. | EBioMedicine | 2022 | 35483273 | PubTator, text mining | PubMed |
| EBAG9 controls CD8+ T cell memory formation responding to tumor challenge in mice. | JCI Insight | 2022 | 35482418 | PubTator, text mining | PubMed |
| Genomewide CRISPR knockout screen identified PLAC8 as an essential factor for SADS-CoVs infection. | Proc Natl Acad Sci U S A | 2022 | 35476513 | PubTator, text mining | PubMed |
| Tissue-resident memory T cells in gastrointestinal cancer immunology and immunotherapy: ready for prime time? | J Immunother Cancer | 2022 | 35470231 | PubTator, text mining | PubMed |
| Transcriptional Profiling and Deriving a Seven-Gene Signature That Discriminates Active and Latent Tuberculosis: An Integrative Bioinformatics Approach. | Genes (Basel) | 2022 | 35456421 | PubTator, text mining | PubMed |
| Integrative diagnosis of primary cutaneous large B-cell lymphomas supports the relevance of cell of origin profiling. | PLoS One | 2022 | 35452489 | PubTator, text mining | PubMed |
| Arachidonic acid, a clinically adverse mediator in the ovarian cancer microenvironment, impairs JAK-STAT signaling in macrophages by perturbing lipid raft structures. | Mol Oncol | 2022 | 35451191 | PubTator, text mining | PubMed |
| Mechanism of cancer stemness maintenance in human liver cancer. | Cell Death Dis | 2022 | 35449193 | PubTator, text mining | PubMed |
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| Engineered cellular immunotherapies in cancer and beyond. | Nat Med | 2022 | 35440724 | PubTator, text mining | PubMed |
| Regulated interaction of ID2 with the anaphase-promoting complex links progression through mitosis with reactivation of cell-type-specific transcription. | Nat Commun | 2022 | 35440621 | PubTator, text mining | PubMed |
| Single cell analyses identify a highly regenerative and homogenous human CD34+ hematopoietic stem cell population. | Nat Commun | 2022 | 35440586 | PubTator, text mining | PubMed |
| A single-cell regulatory map of postnatal lung alveologenesis in humans and mice. | Cell Genom | 2022 | 35434692 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3399/papers?page=34